Risperdal and Cefuroxime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Risperdal (risperidone) and Cefuroxime (cefuroxime sodium). Common drug interactions include mucosal inflammation among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Risperdal and Cefuroxime. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Risperdal?

Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,729 Risperdal users. Check the latest studies of Risperdal.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.



On Jul, 18, 2026

23 people who take Risperdal and Cefuroxime together, and have interactions are studied.

Risperdal and Cefuroxime drug interactions.

What are the common drug interactions of Risperdal and Cefuroxime, by gender? *:

female:

  1. Mucosal inflammation (infection of mucous membrane)
  2. Muscular weakness (muscle weakness)
  3. Neck pain
  4. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  5. Nervousness
  6. Neurological symptom (symptoms of nervous system disease)
  7. Oropharyngeal pain
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  10. Panic attack

male:

  1. Cardiac arrest
  2. Cardiac enzymes increased
  3. Peripheral embolism (sudden interruption of blood flow to an organ or body part)
  4. Sepsis syndrome (a clinical condition of blood infection)
  5. Traumatic brain injury (brain injury due to trauma)
  6. Abnormal behaviour
  7. Alopecia (absence of hair from areas of the body)
  8. Asthenia (weakness)
  9. Balance disorder
  10. Constipation

What are the common drug interactions of Risperdal and Cefuroxime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Nausea (feeling of having an urge to vomit)
  2. Paronychia (infection in the tissues adjacent to a nail on a finger or toe)
  3. Pyrexia (fever)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Skin fissures (a crack in the skin)
  6. Vomiting
  7. Abnormal behaviour
  8. Alopecia (absence of hair from areas of the body)
  9. Asthenia (weakness)
  10. Balance disorder

10-19:

n/a

20-29:

n/a

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Dyspnoea (difficult or laboured respiration)
  3. Nervousness
  4. Pain
  5. Panic attack
  6. Pulmonary embolism (blockage of the main artery of the lung)

40-49:

  1. Chronic kidney disease

50-59:

  1. Anaemia (lack of blood)
  2. Atrioventricular block (heart block)
  3. Cardiac arrest
  4. Cardiovascular disorder (heart diseases)
  5. Collapse (sudden functional breakdown)
  6. Hepatotoxicity (chemical-driven liver damage)
  7. Hypotension (abnormally low blood pressure)
  8. Pain
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Venous thrombosis deep limb (blood clot that forms in a vein deep in the limb)

60+:

  1. Delusion (a false belief or opinion)
  2. Dyspnoea (difficult or laboured respiration)
  3. Pain in extremity
  4. Disbacteriosis (a condition with microbial imbalances on or inside the body)
  5. Cardiac enzymes increased
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Gangrene (body tissue dies)
  9. Groin pain
  10. Heparin-induced thrombocytopenia

What are the existing conditions these people have? *

  1. Pain: 4 people, 17.39%
  2. Chronic Renal Failure (kidney failure): 4 people, 17.39%
  3. Tracheobronchitis (an inflammation or infection, which affects the trachea and bronchi of respiratory tract): 3 people, 13.04%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.04%
  5. Senile Dementia (memory loss with ageing): 2 people, 8.70%
  6. Pneumonia: 2 people, 8.70%
  7. Fever: 2 people, 8.70%
  8. Diabetes: 2 people, 8.70%
  9. Constipation: 2 people, 8.70%
  10. Blood Pressure Abnormal: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Risperdal and Cefuroxime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Risperdal and Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Risperdal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Risperdal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefuroxime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on risperidone and cefuroxime sodium (the active ingredients of Risperdal and Cefuroxime, respectively), and Risperdal and Cefuroxime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: